TY  - GEN
AU  - DeCara,J M
AU  - Croze,S
AU  - Falk,R H
TI  - Generic warfarin: a cost-effective alternative to brand-name drug or a clinical wild card?
SN  - 0012-3692
PY  - 1998///0310
KW  - Aged
KW  - Anticoagulants
KW  - chemistry
KW  - Atrial Fibrillation
KW  - complications
KW  - Biological Availability
KW  - Cerebrovascular Disorders
KW  - prevention & control
KW  - Chemistry, Pharmaceutical
KW  - Clinical Trials as Topic
KW  - Cost-Benefit Analysis
KW  - Drug Costs
KW  - Drugs, Generic
KW  - economics
KW  - Humans
KW  - Patient Selection
KW  - Therapeutic Equivalency
KW  - Thromboembolism
KW  - Warfarin
N1  - Publication Type: Editorial
UR  - https://doi.org/10.1378/chest.113.2.261
ER  -